4.5 Review

The prognosis of idiopathic generalized epilepsy

Journal

EPILEPSIA
Volume 53, Issue 12, Pages 2079-2090

Publisher

WILEY
DOI: 10.1111/j.1528-1167.2012.03723.x

Keywords

Epilepsy; Electroencephalography; Long-term outcome; Remission; Predictors

Funding

  1. National Health and Medical Research Council (Australia)
  2. Australian Research Council
  3. State Government of Victoria, Australia
  4. Novartis Pharmaceuticals
  5. Pfizer Pharmaceuticals
  6. GSK Neurology Australia

Ask authors/readers for more resources

Prognosis describes the trajectory and long-term outcome of a condition. Most studies indicate a better prognosis in idiopathic generalized epilepsy (IGE) in comparison with other epilepsy syndromes. Studies looking at the long-term outcome of different IGE syndromes are relatively scant. Childhood absence epilepsy appears to have a higher rate of remission compared to juvenile absence epilepsy. In absence epilepsies, development of myoclonus and generalized tonicclonic seizures predicts lower likelihood of remission. Although most patients with juvenile myoclonic epilepsy (JME) achieve remission on antiepileptic drug therapy, <20% appear to remain in remission without treatment. Data on the prognosis of other IGE syndromes are scarce. There are contradictory findings reported on the value of electroencephalography as a predictor of prognosis. Comparisons are made difficult by study heterogeneity, particularly in methodology and diagnostic criteria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available